| Before co-founding Bionest in 2003, Alain was European President of Biogen, where he founded its European operation for the launch of Avonex®. Prior to Biogen, he was European Founder of IDEXX Laboratories, a company involved in veterinary diagnostic. And prior to Iddexx, he served as President of Medtronic Europe, a world leader in cardiovascular devices. He started his career in sales and marketing at Abbott's Diagnostic Division and remained there for 17 years, holding a number of key executive positions in the USA and Europe. Today, he specialises in operational issues. |
Claude Allary has three decades of pharmaceuticals industry and management consulting experience, in Europe and North America. He held several corporate and operational finance and marketing positions with Parke-Davis, Rhône-Poulenc Santé and Glaxo. In his 15-year consulting experience, including Arthur D. Little and ISO Healthcare group, he was involved in over 200 projects in healthcare, including strategy and innovation. His main interest is strategy development. |
Before joining Bionest, Frederic was head of Pharma Equity Research and a partner at Exane BNP Paribas. He was head of a research team at GlaxoWellcome, Scientific Consultant for Hoechst and Guest Investigator at the Rockefeller University.
Frederic holds a Ph.D. from the College de France in collaboration with Rhône-Poulenc. He holds an MSc in pharmacology and is a graduate of Ecole Polytechnique. He is also a member of the ACIIA. His expertise lies in science and finance.
|
